Janus Biotherapeutics, Inc. — Form D
Janus Biotherapeutics, Inc. of WELLESLEY, MA, a company, filed a Form D exempt-offering notice with the SEC on 2011-08-19. The offering totals $3.0M, of which $1.1M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2011-08-19
- Form: D
- Accession: 0001514481-11-000003
- Industry: Biotechnology
- Exemptions: 06
- Total offering: $3.0M
- Amount sold: $1.1M
- Remaining: $1.9M
- Investors: 6
- Date of first sale: 2011-08-15
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-164725
Issuer
- Name: Janus Biotherapeutics, Inc.
- CIK: 0001514481
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2010
- Address: 65 WILLIAM STREET, WELLESLEY, MA, 02481
- Phone: 781-705-3024
Officers, directors & promoters (7)
| Name | Role | Location |
|---|
| Steven Bernitz | Director | Wellesley, MA |
| Joseph Baron | Director | Wellesley, MA |
| Joseph Baron | Executive Officer | Wellesley, MA |
| Jonathan Reis | Director | Wellesley, MA |
| Grayson Lipford | Director | Wellesley, MA |
| Grayson Lipford | Executive Officer | Wellesley, MA |
| Christine de los Reyes | Director | Wellesley, MA |
Other filings by this issuer (2)
More